Patent · US Active

Treatment of autoimmune disease

US12364696B2 · kind B2 · utility

0Cited by

2References

18Claims

0Family size

Assignee

JAK Slave Pty Ltd · AU

Inventors

Rodney Sinclair · Thousand Oaks, US
Yuk-Shui Andrew Lau · Melbourne, AU

Key dates

Filing date	Feb 27, 2020
Grant date	Jul 22, 2025
Priority date	—
Expiry date	Apr 21, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2031
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods and compositions for the treatment of autoimmune diseases and of excessive hair shedding or hair loss in a subject or for promoting hair growth in a subject wherein the subject has an autoimmune hair loss disorder, such as alopecia areata. The methods and compositions comprise the administration of a janus kinase inhibitor, such as tofacitinib, wherein the inhibitor is predominantly absorbed through the oral mucosal routes such as the sublingual mucosa.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.